pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07341464: Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

Sponsor: Société des Produits Nestlé (SPN). Phase: NA. Conditions: Cerebral Palsy (CP), Oncology

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07564609: the REMONO-CD and the REMONO-UC Studies

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Crohn Disease (CD), Ulcerative Colitis (UC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07347236: MyNOURISH: Hydrolysed Collagen Supplementation in Older Adults With Fragility Fractures

Sponsor: Hospital Pengajar Universiti Putra Malaysia. Phase: NA. Conditions: Fragility Fracture

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06004232: Prenatal Yoga to Prevent Postpartum Depression

Sponsor: Henry Ford Health System. Phase: NA. Conditions: Postpartum Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07473232: Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

Sponsor: Pamukkale University. Phase: NA. Conditions: Knee Arthritis Osteoarthritis, Platelet Rich Plasma Injection, Conditioned Serum

full page →ctgov ↗
›COMPLETEDphase readoutNCT07522632: Wearable Device to Assess Mobility After Anterior Iliac Grafting Covered With a Regional Block Technique Transversus Abdominis Plane Block

Sponsor: Ain Shams University. Phase: NA. Conditions: Wearable Device, Mobility, Anterior Iliac Grafting, Regional Block Technique, Transversus Abdominis Plane Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT05785832: A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Sponsor: Tandem Diabetes Care, Inc.. Phase: NA. Conditions: Type 2 Diabetes Treated With Insulin

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07375732: Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms

Sponsor: Carnegie Mellon University. Phase: NA. Conditions: Menopausal Depression, Menopause Hot Flashes, Menopause, Menopause Related Conditions

full page →ctgov ↗
›RECRUITINGphase readoutNCT01900132: Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: NA. Conditions: Neuromuscular Disease, Motor Neuron Disease, Inherited Neuromuscular Conditions, Inherited Neuropathies

full page →ctgov ↗
›COMPLETEDphase readoutNCT04128332: Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer

Sponsor: CCTU- Cancer Theme. Phase: NA. Conditions: Cancer of Pancreas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07012798: FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07346287: ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

Sponsor: Stratpharma AG. Phase: PHASE4. Conditions: Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07139106: Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts

Sponsor: New York State Psychiatric Institute. Phase: PHASE4. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07464106: Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.

Sponsor: Robert Bosch Medical Center. Phase: . Conditions: Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Cardio-Renal Syndrome, Frailty

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06831006: Assessing the Effect of Cool Roofs on Health Using Smartwatches in Colima, Mexico

Sponsor: University of Auckland, New Zealand. Phase: NA. Conditions: Heart Rate, All-day Steps, Distance Walked, Active Minutes, Moderate-intensity Activity Minutes, Vigorous-intensity Activity Duration, Sleep Quantity, Time in Sleep Stages, Awake Duration, Sleep Score

full page →ctgov ↗
›COMPLETEDphase readoutNCT05127733: Online Cognitive Behavioural Therapy for Substance Use Disorder: The Impact of Peer Support

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Substance Use Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07467733: Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy

Sponsor: Biocells Medical. Phase: PHASE1. Conditions: Spinocerebellar Ataxia - All Sub-types

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07349615: A Study of SHR-1918 In Participants With Hypertriglyceridemia

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd. Phase: PHASE3. Conditions: Hypertriglyceridemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT03735043: Cardiac Output Monitoring by ccNexfin© in Pregnant Women

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Pregnancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05655078: Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

Sponsor: University College, London. Phase: NA. Conditions: Malignant Pleural Mesothelioma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07239843: Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Phase: . Conditions: Major Depressive Disorder (MDD), Schizophenia Disorder, Bipolar 1 Disorder, Alzheimer Disease, Parkinson Disease, Frontotemporal Dementia (FTD), Dementia With Lewy Bodies (DLB)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07471243: Dressing-related Experiences and Surgical Site Self-care in Hip and Knee Replacement: an Observational Cohort Study

Sponsor: Bournemouth University. Phase: . Conditions: Total Hip Replacement, Total Knee Replacement

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07402135: Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis

Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Noninvasive Biomarkers, Ulcerative Colitis (UC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07391878: Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.

Sponsor: Trigone Pharma Ltd.. Phase: PHASE2. Conditions: Overactive Bladder (OAB)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06538285: Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Sponsor: Nicky Mehtani, MD, MPH. Phase: PHASE2. Conditions: Methamphetamine Use Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00580385: Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Osteosarcoma

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06657885: CAbotégravir LENacapavir DUal Long Acting

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba. Phase: PHASE2. Conditions: HIV1 Infection, Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment, CABOTEGRAVIR, LENACAPAVIR, Stable Oral Antiretroviral Treatment for at Least 6 Months

full page →ctgov ↗
›WITHHELDphase readoutNCT06949085: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT06774443: Hinting Task for Huntington's Disease

Sponsor: University Medical Center Groningen. Phase: . Conditions: Huntington Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07410715: Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)

Sponsor: West China Hospital. Phase: . Conditions: HCC - Hepatocellular Carcinoma, Watch & Wait, Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07419243: Tolerance Results and Immune Mechanisms in Cow´s Milk and/or Hen´s Egg Allergic Children Following Natural Evolution or Oral Immunotherapy

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa. Phase: PHASE1. Conditions: Food Allergy in Children

full page →ctgov ↗
›COMPLETEDphase readoutNCT07498543: Impact of Clinical and Psychological Factors on Satisfaction With Treatment in Psoriatic Patients on Biological Therapy

Sponsor: Catholic University of the Sacred Heart. Phase: . Conditions: Psoriasis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06066515: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Obesity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07302815: Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

Sponsor: Tanta University. Phase: NA. Conditions: Emergence Agitation

full page →ctgov ↗
›COMPLETEDphase readoutNCT05348408: Efficacy of Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropathy

Sponsor: South Egypt Cancer Institute. Phase: PHASE2. Conditions: Chemotherapy-induced Peripheral Neuropathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT05430308: Surgical Site Preparation in Subjects Undergoing Medical Thoracoscopy

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh. Phase: NA. Conditions: Medical Thoracoscopy

full page →ctgov ↗
›COMPLETEDphase readoutNCT05358925: Psychoeducational Videos and Digital Assessments for BPD

Sponsor: Mclean Hospital. Phase: NA. Conditions: Borderline Personality Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02843425: The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Colorectal Cancer Prevention

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02609776: Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Non-Small-Cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04238676: Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain

Sponsor: Persica Pharmaceuticals Ltd. Phase: PHASE1. Conditions: Chronic Low-back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07162376: How Clinical and Personal Information Shape Physicians' Risk Judgments

Sponsor: University of Maryland, College Park. Phase: NA. Conditions: Major Adverse Cardiac Event (MACE)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07358676: A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07362017: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Moderate-to-severe Chronic Plaque Psoriasis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07410689: SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

Sponsor: University of Utah. Phase: NA. Conditions: Cancer, Financial Toxicity

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583589: Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Sponsor: First Affiliated Hospital of Wenzhou Medical University. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis (IPF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06793189: MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL

Sponsor: Ruijin Hospital. Phase: PHASE2. Conditions: Marginal Zone Lymphoma(MZL)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07482189: Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder

Sponsor: China Medical University Hospital. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder, Frozen Shoulder

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05964868: Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

Sponsor: Jessyka Lighthall. Phase: PHASE3. Conditions: Rhinoplasty, Pain Management

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05044468: EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Malignant Pleural Neoplasm

full page →ctgov ↗
›COMPLETEDphase readoutNCT06769750: Variability of Perfusion Index to Predict Hypotension

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Post-spinal Hypotension

full page →ctgov ↗
← prev
page 84 of 161
next →